Keyphrases
Host Immune Response
100%
Mycosis Fungoides
100%
Systemic Chemotherapy
100%
Chemotherapy
50%
Randomized Trial
50%
Cancer Biology
50%
Active Role
50%
Patient Treatment
50%
Interferon-α (IFN-α)
50%
Immune Surveillance
50%
Resistance Mechanisms
50%
Optimal Selection
50%
Advanced Stage
50%
Systemic Approach
50%
Treatment Choice
50%
Cancer Mechanisms
50%
Photopheresis
50%
Drug Usage
50%
Topical Therapy
50%
Interleukin
50%
Psoralen
50%
Durable Response
50%
Immune Effect
50%
Purine Analogues
50%
Biological Response Modifiers
50%
Single Approach
50%
Nursing and Health Professions
Syndrome
100%
Mycosis fungoides
100%
Drug Use
50%
Purine Derivative
50%
Interleukin Derivative
50%
Malignant Neoplasm
50%
Topical Treatment
50%
Photopheresis
50%
Interferon
50%
Purine
50%
Biological Response Modifier
50%
Lack of Drug Effect
50%
Psoralen
50%
Diseases
50%
Medicine and Dentistry
Mycosis fungoides
100%
Immune System
100%
Lack of Drug Effect
50%
Topical Treatment
50%
Photopheresis
50%
Purine
50%
PUVA
50%
Biological Response Modifier
50%
Cancer Pathobiology
50%
Immunosurveillance
50%
Interferon
50%
Interleukin Derivative
50%
Diseases
50%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Syndrome
100%
Mycosis fungoides
100%
Malignant Neoplasm
50%
Purine Derivative
50%
Interleukin Derivative
50%
Interferon
50%
Psoralen
50%
Purine
50%
Biological Response Modifier
50%
Diseases
50%
Immunology and Microbiology
Immune System
100%
Interferon Type I
50%
Immunosurveillance
50%
Biological Response Modifier
50%
Interleukin Derivative
50%